Christopher Esq - UFP Technologies Secretary Counsel
UFPT Stock | USD 321.92 0.00 0.00% |
Executive
Christopher Esq is Secretary Counsel of UFP Technologies
Age | 60 |
Address | 100 Hale Street, Newburyport, MA, United States, 01950-3504 |
Phone | 978 352 2200 |
Web | https://www.ufpt.com |
UFP Technologies Management Efficiency
The company has return on total asset (ROA) of 0.0891 % which means that it generated a profit of $0.0891 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1802 %, meaning that it created $0.1802 on every $100 dollars invested by stockholders. UFP Technologies' management efficiency ratios could be used to measure how well UFP Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, UFP Technologies' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.1 in 2024. At this time, UFP Technologies' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 424.3 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 5.2 M in 2024.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Matthew Jarboe | Paragon 28 | 41 | |
Jonathan Friedman | Paragon 28 | 53 | |
Randy Waddell | Iradimed Co | N/A | |
Sean Wirtjes | Rapid Micro Biosystems | 55 | |
John Shumaker | Paragon 28 | N/A | |
Brenton Taylor | Sight Sciences | 43 | |
Tom Huang | Sight Sciences | N/A | |
Maureen OConnell | Rxsight | N/A | |
Brent Moen | Tactile Systems Technology | 57 | |
Amy Treadwell | Neuropace | N/A | |
Chad Patterson | iRhythm Technologies | 42 | |
Irina Ridley | Neuropace | 38 | |
Julie Dewey | Orthofix Medical | 63 | |
Diane Kaufman | Electromed | N/A | |
David Lehman | Pulmonx Corp | 63 | |
Sherri Ferstler | Tactile Systems Technology | N/A | |
Michael Pisetsky | Si Bone | 46 | |
Kimberley JD | Varex Imaging Corp | 54 | |
Mark Karshner | Orthopediatrics Corp | N/A | |
Andrew Hill | Paragon 28 | 40 | |
Daniel Cher | Si Bone | 59 |
Management Performance
Return On Equity | 0.18 | ||||
Return On Asset | 0.0891 |
UFP Technologies Leadership Team
Elected by the shareholders, the UFP Technologies' board of directors comprises two types of representatives: UFP Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UFP. The board's role is to monitor UFP Technologies' management team and ensure that shareholders' interests are well served. UFP Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UFP Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Bailly, Chairman, CEO and Pres | ||
Steven Cardin, VP MedTech | ||
Jeffrey CPA, CEO Chairman | ||
Mitchell Rock, Sr. VP of Sales and Marketing | ||
Jason Holt, Chief Officer | ||
Christopher Esq, Secretary Counsel | ||
Ronald Lataille, CFO, Sr. VP, Treasurer and Secretary | ||
Steve Cardin, VP MedTech | ||
Daniella Mehalik, Vice Finance |
UFP Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UFP Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.18 | ||||
Return On Asset | 0.0891 | ||||
Profit Margin | 0.12 % | ||||
Operating Margin | 0.18 % | ||||
Current Valuation | 2.68 B | ||||
Shares Outstanding | 7.67 M | ||||
Shares Owned By Insiders | 5.40 % | ||||
Shares Owned By Institutions | 94.90 % | ||||
Number Of Shares Shorted | 670.71 K | ||||
Price To Earning | 65.63 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for UFP Stock Analysis
When running UFP Technologies' price analysis, check to measure UFP Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UFP Technologies is operating at the current time. Most of UFP Technologies' value examination focuses on studying past and present price action to predict the probability of UFP Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UFP Technologies' price. Additionally, you may evaluate how the addition of UFP Technologies to your portfolios can decrease your overall portfolio volatility.